Brother or sister donor transplant using kidney and stem cells
Part of Blood & lymphatic, Kidney & urinary clinical trials.
This study tests a combined approach for kidney transplant patients: standard living-donor kidney transplant plus an added “stem cell” component taken from the same sibling donor. It aims to improve transplant outcomes by trying to better control the immune response and reduce complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need a living kidney transplant from an HLA-identical brother or sister at UCLA
- You must be able to consent, and you’ll live within about 3 hours of UCLA for the first 3–6 months
- Your blood counts, heart, lungs, and liver must meet study safety thresholds
- You must not have certain infections or immune-system test results (like HIV) and must be able to follow monitoring
- If you can become pregnant, you must have a negative pregnancy test and use reliable birth control for 12 months after transplant
- You must not have recent certain immune-suppressing medicines, immune therapy drugs, or recent major cancer activity
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a special stem cell treatment (using your own stem cells) can reset your immune system so you can accept a kidney from a deceased donor, even if you have very high antibody levels that make it hard to find a match. It's for people who have been waiting a long time and haven't had a transplant offer.
This study tests whether receiving a thymus and kidney from the same baby donor can help your body accept the new kidney without needing strong anti-rejection drugs. It is for people who need a kidney transplant and are willing to also receive a thymus from the same donor.
This Phase 1 study tests a treatment plan given after a kidney transplant to help the immune system stay calm and reduce the risk of rejection. Participants must have a well-functioning kidney transplant from a closely matched living donor and meet health and safety requirements.
This trial tests a way to help your body accept your liver transplant without needing lifelong anti-rejection drugs. It uses your living donor's stem cells to train your immune system to not attack the new liver.
This study tries to use a stem cell transplant from your original kidney donor to help your body accept the kidney without needing lifelong anti-rejection drugs. You must have a perfectly matched sibling donor who is still available.
This trial tests a combination of low-dose radiation, chemotherapy, and donor immune cells to help your body accept a living donor kidney without long-term anti-rejection drugs.
Hear when a new Renal Transplant Rejection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.